Cerluten vs Cortexin
Comparison of Cerluten (Low evidence) and Cortexin (Moderate evidence).
Last updated: February 12, 2026
Cerluten
Cortexin
Overview
Cerluten and Cortexin are both studied in the peptide research space.
Cerluten: A cytamin-class peptide supplement derived from brain tissue, part of the Russian bioregulator framework.
Cortexin: A Russian neuropeptide complex derived from porcine or bovine cerebral cortex, approved in Russia and CIS countries for neurological conditions.
Evidence Comparison
| Aspect | Cerluten | Cortexin |
|---|---|---|
| Evidence Level | Low | Moderate |
| Human Studies | 1 | 12 |
| Preclinical Studies | 6 | 16 |
| Total Sources | 8 | 28 |
Key Differences
| Aspect | Cerluten | Cortexin |
|---|---|---|
| Category | Cognitive | Cognitive |
| Evidence Strength | Low | Moderate |
| Total Sources | 8 | 28 |
| Human Studies | 1 | 12 |
Summary
- Cerluten: Low evidence with 8 total sources (1 human)
- Cortexin: Moderate evidence with 28 total sources (12 human)
This comparison is for educational purposes only and is not medical advice. Consult a healthcare professional before making any decisions about peptide use.
View Full Dossiers
Stay Updated on Peptide Comparisons
Get notified when we publish new comparison dossiers and evidence reviews.
No spam. Unsubscribe anytime.
Disclaimer: This comparison is for educational purposes only and does not constitute medical advice. Individual responses to medications vary. Always consult a qualified healthcare provider before making treatment decisions.